Kuros Biosciences AG/€KURN
1D1W1MYTD1Y5YMAX
Capital at risk
About Kuros Biosciences AG
Kuros Biosciences AG is a biotechnology company based in Switzerland, focused on the development of products for tissue repair and regeneration. Core to its business are biomaterial-based products designed to support bone healing in specific medical conditions. Its product portfolio includes innovative solutions like MagnetOs, used for spinal fusion; it is designed to enhance the body’s natural bone healing process. The company, headquartered in Schlieren, Switzerland, leverages its proprietary technologies to target significant unmet medical needs, positioning itself in the niche market of orthobiologics. Kuros Biosciences emphasizes innovation in biologics and synthetic solutions, aiming for a competitive edge in the healthcare sector.
- Ticker
- €KURN
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 178
- Headquarters
- Schlieren, Switzerland
- Website
- kurosbio.com
KURN Metrics
BasicAdvanced
€691M
92.90
€0.19
0.76
-
Price and volume
Market cap
€691M
Beta
0.76
52-week high
€37.10
52-week low
€17.45
Average daily volume
233K
Financial strength
Profitability
EBITDA (TTM)
11.65
Gross margin (TTM)
86.37%
Net profit margin (TTM)
5.13%
Operating margin (TTM)
6.07%
Effective tax rate (TTM)
17.23%
Revenue per employee (TTM)
€853,230
Management effectiveness
Valuation
Price to earnings (TTM)
92.899
Price to revenue (TTM)
4.433
Growth
Revenue change (TTM)
42.45%
Earnings per share change (TTM)
-238.27%
3-year revenue growth (CAGR)
90.56%
10-year revenue growth (CAGR)
61.53%
3-year earnings per share growth (CAGR)
-27.09%
10-year earnings per share growth (CAGR)
-27.73%
Upcoming events
No upcoming events
Funds containing KURN
AllEURGBP
Fund name | Fund size | €KURN weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.04% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.04% |
SPDR MSCI All Country World IM€SPYI | €7.5B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.